Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Jiangsu Alphamab Biopharmaceuticals Co., Ltd

Clinical trials sponsored by Jiangsu Alphamab Biopharmaceuticals Co., Ltd, explained in plain language.

Trials to join now! 2 Not yet recruiting 4 Not yet finished but already full! 1 Terminated 1

New cancer drug trial halted early – only 11 patients enrolled

Disease control Terminated

This study tested a new drug called JSKN033 in 11 people with advanced solid tumors that have a protein called HER2. The goal was to see if the drug is safe and what dose works best. The trial was stopped early, so results are limited.

Phase: PHASE1, PHASE2 • Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd • Aim: Disease control

Last updated May 14, 2026 12:05 UTC